本頁面由Tiger Trade Technology Pte. Ltd.提供服務

Arcutis Biotherapeutics Inc.

24.58
-0.5100-2.03%
盤前24.990.4100+1.67%05:53 EDT
成交量:77.55萬
成交額:1,904.45萬
市值:30.49億
市盈率:-193.76
高:25.33
開:25.09
低:24.21
收:25.09
52周最高:31.77
52周最低:12.42
股本:1.24億
流通股本:8,824.23萬
量比:0.73
換手率:0.88%
股息:- -
股息率:- -
每股收益(TTM):-0.1269
每股收益(LYR):-0.1269
淨資產收益率:-9.30%
總資產收益率:-1.95%
市淨率:16.09
市盈率(LYR):-193.76

資料載入中...

2024/02/12

超過5%披露

Form SC 13G - Statement of acquisition of beneficial ownership by individuals
2024/02/06

SEC問詢函

Form CORRESP - Correspondence
2024/01/31

超過5%披露

Form SC 13G - Statement of acquisition of beneficial ownership by individuals
2024/01/25

SEC問詢函

Form CORRESP - Correspondence
2024/01/11

重要事件披露

Form 8-K - Current report
2024/01/03

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2023/12/22

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2023/12/18

重要事件披露

Form 8-K - Current report
2023/11/30

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2023/11/22

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2023/11/17

超過5%披露

Form SC 13G - Statement of acquisition of beneficial ownership by individuals
2023/11/10

超過5%披露

Form SC 13G - Statement of acquisition of beneficial ownership by individuals
2023/11/03

季度報告

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2023/11/03

重要事件披露

Form 8-K - Current report
2023/10/31

超過5%披露

Form SC 13G - Statement of acquisition of beneficial ownership by individuals
2023/10/26

超過5%披露

Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend]
2023/10/24

重要事件披露

Form 8-K - Current report
2023/10/19

重要事件披露

Form 8-K - Current report
2023/09/27

重要事件披露

Form 8-K - Current report
2023/09/16

[修訂]年度報告

Form 10-K/A - Annual report [Section 13 and 15(d), not S-K Item 405]: [Amend]